Company Executives

Letter Agreement lock-up on Class B ordinary shares held by the Original Sponsor, with SSVK and Insiders, amended February 13, 2024 to six months after the initial business combination.

Sponsor Advisory Services Fee payable to SSVK for advisory services, reduced from $2.0 million to $500,000 and then to $250,000.

Conversion Agreements under which the company issued 3,480 shares of common stock to SSVK and Mr. Ajjarapu for services at an effective price of $500.00 per share.

Amended and restated registration rights agreement covering resale registration of registrable securities for SSVK, the Original Sponsor, Dr. Saadi, Mr. Desai, Dr. Neal Flomenberg and Cantor.

New lock-up agreement restricting transfers of securities held by SSVK, Mr. Ajjarapu and Dr. Saadi, which has expired.

Employment of Mittul Mehta as Chief Information Officer and Head of Tevogen AI with a 2025 base salary.

Securities purchase agreement for Series A Preferred Stock, amended to reduce the purchase price from $8.0 million to $2.0 million.

Agreement to purchase Series A-1 Preferred Stock convertible into 12,000 shares of common stock.

Assignment and assumption of liabilities by SSVK in exchange for Series B Preferred Stock, later repurchased and cancelled on June 15, 2024.

Purchase of 600 shares of Series C Preferred Stock convertible into common stock, with a 7.5% cumulative dividend.

Unsecured line of credit facility from the Patel Family up to $36.0 million, plus a contingent option to purchase at least $14.0 million of common stock; 20,000 commitment shares issued.

Advisory services consulting agreement under which Dr. Patel was granted 120,000 RSUs.

Grants from KRHP to the company, including $2,000,000 in January 2025 and $1,000,000 in August 2025, with an additional $7,000,000 committed.

Sale of prefunded warrants exercisable for 375,000 shares of common stock.

Cash contribution to the company from Dr. Saadi.